Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men

John Alden Lee, Ranjith Ramasamy

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

Hypogonadism among men desiring fertility preservation presents a unique challenge to physicians. Over the past decade the number of younger men with hypogonadism has increased dramatically. These men are often treated with testosterone replacement therapy (TRT) which can result in azoospermia and potentially infertility. Human chorionic gonadotropin (hCG) therapy can help re-establish or maintain spermatogenesis in hypogonadal men. We review the indications, and discuss the current evidence for the role of hCG in men with hypogonadisms.

Original languageEnglish (US)
Pages (from-to)S348-S352
JournalTranslational Andrology and Urology
Volume7
DOIs
StatePublished - Jul 1 2018

Keywords

  • Anabolic androgenic steroids (AAS)
  • Human chorionic gonadotropin (hCG)
  • Hypogonadal hypogonadism
  • Hypogonadism
  • Infertility
  • Testosterone replacement therapy (TRT)

ASJC Scopus subject areas

  • Reproductive Medicine
  • Urology

Fingerprint Dive into the research topics of 'Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men'. Together they form a unique fingerprint.

  • Cite this